Navigation Links
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Date:3/9/2010

d by a world-class antiviral drug development team, Chimerix is advancing programs to address cytomegalovirus (CMV), BK virus, adenovirus, smallpox, human immunodeficiency virus (HIV), hepatitis C virus (HCV), respiratory syncytial virus (RSV) and influenza.  The company's lead compound, CMX001, is in Phase 1 and 2 clinical studies for the treatment of BK virus and CMV, potentially deadly infections among immunocompromised patients.  CMX001 is also being developed as a biodefense countermeasure in the event of a smallpox release.  CMX157, a late-stage preclinical candidate, is a new chemical entity created by applying Chimerix's PIM (Phospholipid Intramembrane Microfluidization) conjugation technology to chemically modify tenofovir, an approved HIV drug.  CMX157 is being developed as a potential once-weekly nucleoside analogue against HIV infections.  Building on the company's extensive chemical library, Chimerix is also pursuing translational medicine efforts to address malaria, dengue fever and other public health needs.  Chimerix has received financing from leading venture capital firms, including Sanderling Ventures, Canaan Partners, Alta Partners, Asset Management Company and Frazier Healthcare Ventures, as well as significant funding from the National Institute of Allergy and Infectious Diseases.  Additional information about Chimerix and its antiviral drug development programs may be found online at http://www.chimerix.com.

SOURCE Chimerix, Inc.

Back to top
'/>"/>
SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
2. Chimerix to Present at Two Upcoming Investor Conferences
3. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
4. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
5. ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
6. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
9. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
10. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
11. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 DePuy Synthes CMF* today announced ... first commercially available biosynthesized dural replacement derived from cellulose ... part of the DePuy Synthes Companies of Johnson & ... that covers and protects the brain and spinal cord. ... surgeons to access the brain. A dural graft, which ...
(Date:5/4/2015)... 2015 Thirty-six million Americans suffer from hearing ... – National Hearing Month – more than 28 million ... on the sounds of spring, like birds singing and ... ensure that you won,t be among those missing out ... Inc. offers practical advice: Take action if ...
(Date:5/4/2015)... , May 4, 2015 RadiologyAuction will have ... live video and product demonstrations at the end of ... equipment such as Kodak and Fuji Cr,s, Agfa and ... at the first event. Various imaging equipment will be ... . After years of buying and selling ...
Breaking Medicine Technology:DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 2DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery 3It's Better Hearing Month 2RadiologyAuction Announces Event Starting On May 5th 2
(Date:5/5/2015)... After conducting a nationwide executive search ... West Holt Medical Services in Atkinson, Neb., ... skilled healthcare executive with more than 10 years of ... June 1st. , “Brad brings a proven track record ... and success in building strong relationships with physicians,” said ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Dealing with injuries ... strenuous and complicated task. Personal injury lawyers are excellent resources ... created equal. In their latest article , the Jones ... search for when choosing a personal injury lawyer to handle ... injury case is a waste of time if the lawyer ...
(Date:5/5/2015)... McMunn Associates , a leader ... announced today that it has officially launched a new ... to president and founder, Larry McMunn, the new web ... strategy for growth and expansion for the next several ... 30 years by building close, personal relationships with clients. ...
(Date:5/5/2015)... 2015 Mercy Health (formerly Catholic Health ... Kentucky – has devoted the sixth of its monthly ... obesity issues. Experts say one in three youngsters is ... Mercy Health’s YouTube channel, a Mercy Health expert addresses ... childhood obesity worse now than when we were kids? ...
(Date:5/5/2015)... Swiftwick, a leading athletic performance sock company, ... sponsor. The partnership launched May 3, 2015, at the ... is an innovative, untimed community race where participants will ... COLORDASH. At each kilometer of the race, they will ... color move them.” , The organization demonstrates their commitment ...
Breaking Medicine News(10 mins):Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2Health News:McMunn Associates Launches New Corporate Branding with New Website 2Health News:Videos provide helpful information about childhood obesity 2Health News:Swiftwick Partners with COLORDASH as Presenting Sponsor 2
... in Arts & Sciences at Washington University in St. Louis ... peace loving race in earlier times. // Sussman made these ... Menu," during the American Association for the Advancement of the ... ,In his new book "Man the Hunted: ...
... Chronic Wasting Disease (CWD) in Alberta led to the killing of ... area. This is an effort to curb the spread of chronic ... Ealey said that these measures can prevent the spread of the ... deer among high-risk areas is virtually the only way to reduce ...
... of Jerusalem researchers report that another health benefit of grapefruit ... result it reduces the incidence of heart disease. // ... one grapefruit daily can significantly reduce the levels of cholesterol ... eat the fruit. This study is relevant in the reduction ...
... of Medicine is at the forefront of the mission to ... It is one among 13 schools to have been chosen ... Howard Hughes Medical Institute. ,"The gap between basic ... associate dean for research and education at the School of ...
... compound, CDDO-Im, shown to possess strong anti-tumor properties in ... treatment of liver cancer patients. // The compound has ... (cancer causing substances) by enhancing the function of enzymes ... the compound have been published in the journal Cancer ...
... The need for effective disinfection of anthrax spores was ... // It has now been found that anthrax spores ... due to their improved ability to attach and adapt ... researchers have therefore pointed out to the need for ...
Cached Medicine News:Health News:Early Man Was A Prey Rather Than A Predator 2Health News:One fruit that has captured the health benefit sector is Grapefruit! 2Health News:Getting Basic Science to Work For Medicine 2Health News:New Compound Offers Hope In Liver Cancer Treatment 2Health News:Anthrax Spores May Resist Water Treatment 2
Research Series 2100 Adjustable-volume Pipette, 2.0-20 l, single-channel with adjustable-volume setting...
... The Ulti-Mist™ HME product line has the ... pediatrics to adults and from intubated patients ... superior humidification for both anesthesia and critical ... HME/Filters provide maximum protection for patients and ...
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
... line has the right product for any ... from intubated patients to patients with tracheotomies. ... anesthesia and critical care applications., ,The ... for patients and staff members. This entire ...
Medicine Products: